Cargando…
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines
Concern has arisen about hypersensitivity reactions in patients with allergic reactions to drugs containing polyethylene glycol (PEG) or polysorbate 80 (PS80), excipients of currently available anti-SARS-CoV-2 mRNA vaccines. However, the actual utility of PEG and PS80 skin allergy testing is current...
Autores principales: | Nappi, Emanuele, Racca, Francesca, Piona, Alessandra, Messina, Maria Rita, Ferri, Sebastian, Lamacchia, Donatella, Cataldo, Giuseppe, Costanzo, Giovanni, Del Moro, Lorenzo, Puggioni, Francesca, Canonica, Giorgio Walter, Heffler, Enrico, Paoletti, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222408/ https://www.ncbi.nlm.nih.gov/pubmed/37243019 http://dx.doi.org/10.3390/vaccines11050915 |
Ejemplares similares
-
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital
por: Paoletti, Giovanni, et al.
Publicado: (2023) -
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital()
por: Paoletti, Giovanni, et al.
Publicado: (2021) -
Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions
por: Messina, Maria Rita, et al.
Publicado: (2023) -
Endotyping of IgE-mediated polyethylene glycol and/or polysorbate 80 allergy.
por: Ieven, Toon, et al.
Publicado: (2023) -
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model
por: Malipiero, Giacomo, et al.
Publicado: (2020)